These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3677676)

  • 1. The effect of acetylsalicylic acid on menstrual blood loss in women with IUDs.
    Pedrón N; Lozano M; Gallegos AJ
    Contraception; 1987 Sep; 36(3):295-303. PubMed ID: 3677676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menstrual blood loss, haemoglobin and ferritin concentration of Beijing women wearing steel ring, VCu 200, and TCu 220c IUDs.
    Gao J; Zeng S; Sun BL; Wu SC; Dong J; Cong J; Zhu XH; Fan HM; Han LH; Xie Z
    Contraception; 1986 Dec; 34(6):559-71. PubMed ID: 3829674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of acetylsalicylic acid and paracetamol on menstrual blood loss in women with and without an intrauterine contraceptive device.
    Hahn L; Petruson B
    Am J Obstet Gynecol; 1979 Oct; 135(3):393-6. PubMed ID: 484632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menstrual bleeding with copper-covered intrauterine contraceptive devices.
    Malmqvist R; Petersohn L; Bengtsson LP
    Contraception; 1974 Jun; 9(6):627-33. PubMed ID: 4448089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hypermenorrhea with mefenamic acid in women using IUDs.
    Pedron N; Lozano M; Aznar R
    Contracept Deliv Syst; 1982 Apr; 3(2):135-9. PubMed ID: 12338167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menstrual blood loss in IUD users: comparative study of eleven different IUDs in Mexican women.
    Pedron N
    Adv Contracept Deliv Syst; 1995; 11(3-4):245-53. PubMed ID: 12290877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative studies on menstrual blood loss in IUD users.
    Andrade AT; Pizarro Orchard E
    Contraception; 1987 Jul; 36(1):129-44. PubMed ID: 3311622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of copper surface area on menstrual blood loss and iron status in women fitted with an IUD.
    Milsom I; Rybo G; Lindstedt G
    Contraception; 1990 Mar; 41(3):271-81. PubMed ID: 2323218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced menstrual blood loss by release of an antifibrinolytic agent from intrauterine contraceptive devices.
    Tauber PF; Kloppel A; Goodpasture JC; Burns J; Ludwig H; Zaneveld LJ
    Am J Obstet Gynecol; 1981 Jun; 140(3):322-8. PubMed ID: 7246636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia.
    Irvine GA; Campbell-Brown MB; Lumsden MA; Heikkilä A; Walker JJ; Cameron IT
    Br J Obstet Gynaecol; 1998 Jun; 105(6):592-8. PubMed ID: 9647148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menstrual blood loss estimates in women using copper 7 and multiload-250 intrauterine devices.
    Pedrón N; Gallegos AJ; Lozano M; Aznar R
    Contraception; 1982 Nov; 26(5):475-85. PubMed ID: 7160180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine system.
    Wildemeersch D; Rowe PJ
    Contraception; 2005 Jun; 71(6):470-3. PubMed ID: 15914139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of baseline menstrual bleeding pattern on copper intrauterine device continuation.
    Hobby JH; Zhao Q; Peipert JF
    Am J Obstet Gynecol; 2018 Nov; 219(5):465.e1-465.e5. PubMed ID: 30170037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measured menstrual blood loss in women with a bleeding disorder or using oral anticoagulant therapy.
    van Eijkeren MA; Christiaens GC; Haspels AA; Sixma JJ
    Am J Obstet Gynecol; 1990 May; 162(5):1261-3. PubMed ID: 2339725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hysterographic orientation of IUDs in relation to menstrual blood loss.
    Kandil O; Aref I; El-sheikha Z; Radwan MM; El-agizi H; Hassanein MK
    Contracept Deliv Syst; 1983 Jul; 4(3):213-7. PubMed ID: 12265365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The menstrual cycle in women using an intrauterine device.
    Faundes A; Segal SJ; Adejuwon CA; Brache V; Leon P; Alvarez-Sanchez F
    Fertil Steril; 1980 Nov; 34(5):427-30. PubMed ID: 7439408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of levonorgestrel and copper releasing intrauterine contraceptive device on body iron stores and menstrual bleeding patterns: experience on Indian women.
    Rana M; Saxena P; Firdous N
    Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):230-4. PubMed ID: 22428475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.